Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

for
Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer
Location: Boston MA, New York NY, Philadelphia PA, Miami FL,
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT03686124

Phase 1, Phase 2, Recruiting

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer or Malignant Peritoneal Mesothelioma

for
Mesothelin Positive, Mesothelin-Expressing Tumors,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06623396

Phase 1, Recruiting

A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

for
Advanced Cancer, Metastatic Solid Tumor
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 1 - 25

Code: NCT05004116

Phase 1, Phase 2, Recruiting

Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors

for
Metastatic Bladder Urothelial Carcinoma,
Location: Chicago IL, Orland Park IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT06630416

Phase 2, Recruiting

Genetic Testing for the Prevention of Cancer in American Indian Communities (JUNIPER Trial)

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06569316

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Addressing Tetrachloroethylene Exposure in an Impacted Community

for
Vapors; Inhalation, Cancer, Volatile Organic Compounds
Location: West Lafayette IN
Sponsor: Purdue University

Sex: All

Age: 18 - 70+

Code: NCT05819996

Recruiting

Transportation for Cancer Care Navigation Tool for Reducing Travel Barriers Among Patients With Solid Tumors Receiving Radiation Therapy

for
Malignant Solid Neoplasm
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT06541158

Recruiting

Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

for
Solid, Liquid, Central Nervous System Tumors
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0+

Code: NCT02530658

Recruiting

Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer - COHORT 2

for
Gynecologic Cancer, Chemotherapy-induced Peripheral Neuropathy
Location: Middletown CT, Hartford CT, Durham NC, Roanoke VA
Sponsor: Duke University

Sex: Female

Age: 18+

Code: NCT06139458

Recruiting

Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

for
Lung Non-Small Cell Carcinoma, Malignant Solid Neoplasm,
Location: Irvine CA, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT05830058

Phase 2, Recruiting

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

for
Cancer
Location: New York NY, New Brunswick NJ, Philadelphia PA,
Sponsor: MBrace Therapeutics

Sex: All

Age: 18+

Code: NCT06014658

Phase 1, Phase 2, Recruiting

A Study of ASP1002 in Adults for Treatment of Solid Tumors

for
Advanced Solid Tumors
Location: Plainville CT, New Haven CT, New York NY, Fairfax VA,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT05719558

Phase 1, Recruiting

The Use of Indocyanine Green as a Diagnostic Adjunct for Pediatric Solid Malignancies

for
Metastatic Disease, Primary Tumor, Solid Malignancies
Location: Cincinnati OH
Sponsor: Roshni Dasgupta

Sex: All

Age: 0 - 45

Code: NCT04492735

Recruiting

Molecular Genetics Studies of Cancer Patients and Their Relatives

for
Malignant Neoplasm
Location: Brighton MA, Mount Kisco NY, Poughkeepsie NY,
Sponsor: City of Hope Medical Center

Sex: All

Age: 0+

Code: NCT04185935

Recruiting

Food and Microbiome Longitudinal Investigation (FAMiLI)

for
Cancer, Cardiovascular Diseases
Location: New York NY
Sponsor: NYU Langone Health

Sex: All

Age: 40+

Code: NCT03293758

Recruiting

An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Boston MA, New York NY, Philadelphia PA, Fairfax VA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06589596

Phase 1, Recruiting

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

for
Cancer, All Types, Cancer of Liver, Cancer of Stomach,
Location: Gainesville GA
Sponsor: SpeciCare

Sex: All

Age: 0 - 70+

Code: NCT03896958

Recruiting

Promoting Access, Resources and Treatment Through Novel and Equitable Solutions for Cancer Care

for
Cancer
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06481774

Recruiting

International Rare Brain Tumor Registry

for
Astroblastoma, BCOR ITD Sarcoma, CNS Sarcoma,
Location: Washington D.C. DC, Akron OH, Cincinnati OH, Chicago IL,
Sponsor: Children's National Research Institute

Sex: All

Age: 0 - 45

Code: NCT05697874

Recruiting

Establish ProLung Test Measurement Collection Protocol for Future Studies.

for
Cancer , Healthy
Location: Maywood IL, Ogden UT, Salt Lake City UT, Encinitas CA
Sponsor: Fresh Medical Laboratories

Sex: All

Age: 18+

Code: NCT04134520

Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial